FENNEC PHARMACEUTICALS
(31447P100)
ファンドの報告 FENNEC PHARMACEUTICALS 13F提出書類による
| 商号 | 保有株式/元本 | 市場価格 | オプション | 報告期間 | 有効日 |
|---|---|---|---|---|---|
| Venbio Select Advisor LLC | 1,105,999 | $4,424k | Jun 30, 2019 | Aug 14, 2019 | |
| 683 Capital Management LLC | 971,351 | $3,885k | Jun 30, 2019 | Aug 14, 2019 | |
| Solas Capital Management LLC | 849,979 | $3,400k | Jun 30, 2019 | Aug 14, 2019 | |
| Eventide Asset Management LLC | 720,000 | $2,880k | Jun 30, 2019 | Aug 14, 2019 | |
| Granahan Investment Management Inc | 439,083 | $1,756k | Jun 30, 2019 | Aug 14, 2019 | |
| Opaleye Management Inc | 295,000 | $1,180k | Jun 30, 2019 | Aug 14, 2019 | |
| Prelude Capital Management LLC | 302 | $1k | Jun 30, 2019 | Aug 14, 2019 |